openPR Logo
Press release

Global Antibody Production Market to witness Impressive Growth by 2016 – 2024

03-28-2017 12:45 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ZMR

Global Antibody Production Market to witness Impressive Growth

Zion Market Research, the market research group announced the analysis report titled "Antibody Production Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024"

Global Antibody Production Market: Overview

The immune system produces antibodies secreted in the blood, which are protein molecules produced in response to the antigens, foreign particles such as virus, fungi, and bacteria. The antibodies function by neutralizing or inhibiting the antigen activity. The production of an antibody is dependent on the humoral response of the immune system on the introduction of foreign particles into the body. Polyclonal antibodies and monoclonal antibodies are the basic types of antibodies produced by the immune system. Polyclonal antibodies are produced from many dissimilar immune cells whereas monoclonal antibodies are produced by similar immune cells which are duplicates of a distinctive progenitor cell. The antibody production market consists of products essential for various steps of processing of antibodies, such as downstream processing, filtration, and upstream processing.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/antibody-production-market

Global Antibody Production Market: Growth Factors

The major factors contributing to the growth of antibody production market are the increasing need for protein curatives and rising widespread presence of infectious disease. The other factors propelling the growth of the market are the patent cessation of successful monoclonal antibodies, raised R&D disbursement of biotechnology and pharmaceutical companies, rising acceptance of targeted immunotherapy and therapeutic antibodies by governing authorities.

Global Antibody Production Market: Segmentation

The antibody production market may be classified based on end users and process. The end users segment of the global market can be further divided into research institutes, diagnostic laboratories, and biotechnology and pharmaceutical companies. The biotechnology and pharmaceutical companies segment is anticipated to grow the most owing to the huge digit of drug development processes to meet the decreased industry timelines, attracting the companies to invest in the developmental and research activities. The process segment of the market may be divided into filtration, upstream processing, and downstream processing. The filtration segment of the market can be further categorized as filtration consumables and accessories and filtration systems. The upstream segment of the global antibody production market can be diversified into consumables and bioreactors. The consumables segment is sub-segmented as buffers & reagents and media and bioreactors segment is sub-segmented as single-use bioreactors and large-scale bioreactors. The downstream segment can be categorized into chromatography resins and chromatography systems. The need for advanced and sensitive tools is expected to boost the growth of downstream processing segment.

The antibody production market can also be segmented on the basis of application and type. The application segment of the market is further classified into cardiology, rheumatology, hematology/oncology, gastroenterology, transplantation, and infection. The type segment of the antibody production market can be categorized into polyclonal antibodies and monoclonal antibodies. The monoclonal antibody segment is further sub-segmented into humanized, murine, and chimeric.

Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/antibody-production-market

Global Antibody Production Market: Regional Analysis

North America is anticipated to be the rapidly growing region in the antibody production market due to the government expenditure, increasing cancer incidence, and the requirement for quality cancer therapy. The Asia-Pacific region is also expected to boost in the market owing to rising private sector and government expenditure, increasing infrastructural advancements, and government support.

Global Antibody Production Market: Competitive Players

The major players in the antibody production market are Sigma-Aldrich Corporation, GE Healthcare, Thermo Fisher Scientific, Inc., INTEGRA Biosciences AG, Cellab GmbH, and Eppendorf AG. The other prominent players in the market include Sartorius AG, Pall Corporation, Merck KGaA, and FiberCell Systems Inc.

Browse detail report @ https://www.zionmarketresearch.com/report/antibody-production-market

Global Antibody Production Market: Regional Segment Analysis

North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

What Report Provides

Full in-depth analysis of the parent market
Important changes in market dynamics
Segmentation details of the market
Former, on-going, and projected market analysis in terms of volume and value
Assessment of niche industry developments
Market share analysis
Key strategies of major players
Emerging segments and regional markets
Testimonials to companies in order to fortify their foothold in the market.

Ask for a customized report @ https://www.zionmarketresearch.com/custom/695

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
4283, Express Lane,
Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: http://www.zionmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antibody Production Market to witness Impressive Growth by 2016 – 2024 here

News-ID: 484032 • Views: 287

More Releases from ZMR

01-23-2019 | Health & Medicine
ZMR
Medical Aesthetic Devices Market Forecast $ 11.20 Bn by 2021 with major players, …
Some of the major companies in the global medical aesthetic devices market are Alma Lasers, Merz, Inc., Cutera, Inc., Allergan plc, Cynosure, Inc., Galderma S.A., Solta Medical, Inc., Syneron Medical Ltd., Mentor Worldwide LLC, Lumenis Ltd., and ZELTIQ Aesthetics, Inc. These players are set to bolster the growth of the medical aesthetic devices market in the years to come. According to the analysts at Zion Market research, in 2015, the
01-22-2019 | Energy & Environment
ZMR
Global Smart Grid Market rising inflation rates USD 60.29 Billion By 2024
Zion Market Research has published a new report titled “Smart Grid Market by Technology (Advanced Metering Infrastructure, Distribution Automation, Software & Hardware, Communication Service, Cyber Security, and Transmission Upgrades) and by Service (Consulting, Deployment & Integration, and Support & Maintenance): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2024”. According to the report, the global smart grid market valued at approximately USD 29.86 billion in 2017 and is expected to generate
Global Smart Toys Market Analysis, 2017 – 2024 with key players, Dream Interna …
Zion Market Research has published a new report titled “Smart Toys Market By Type (Screenless Toys, App-Enabled Mechanical Toys, Voice or Image Recognition Toys, Health-Tracking Toys or Wearable, Toys-To-Life, Puzzles and Building Games, and Others), By Technology (Wi-Fi, Bluetooth, RFID or NFC), By Distribution Channel (Toy shops, E-Commerce Or Online Stores, Offline Stores, Specialty Stores, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024”. According to the
Global footwear market is displaying a highly competitive business, 2017 – 202 …
Adidas AG, Nike Inc., New Balance Inc., Puma SE, Asics Corporation, and Bata Ltd are some of the key vendors of footwear across the world. These players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the footwear market

All 5 Releases


More Releases for Antibody

Global Antibody Drug Conjugates Market Insights, Forecast
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement
Procalcitonin Antibody Market Opportunity Analysis, 2018 - 2026
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin
Procalcitonin Antibody Market
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E.coli Scope of the Report: This report focuses on the Procalcitonin
Global Combination Antibody Therapy Market | MarketResearchReports.biz
Latest industry research report on: Global Combination Antibody Therapy Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts In its recently published report titled Combination Antibody Therapy Market: Global Industry Analysis and Forecast, 2016-2024, Persistence Market Research reviews the global combination antibody therapy market for an eight year forecast period (2016 2024). This research report provides a detailed analysis of the global combination antibody therapy market
Antibody Drug Conjugate Market Opportunity Analysis
Ever since the first attempt in the 1980's to use antibody-based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the
Global Antibody Drug Conjugate Market & Pipeline Insight2020
Pharmaceutical companies are trying to develop better therapeutics in order to overcome large unmet medical necessities. Currently available therapeutics suffers from various caveats like low specificity, low potency and severe adverse effects. This scenario has caused the pharmaceutical companies to develop therapeutics that can succeed these limitations. They have been able to overcome these problems and improve their medical conditions by commercializing ADC. They are rapidly gaining acceptance across the